Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 224
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #225: Q1 Lobbying Update; Individual vs. Group MDMA Therapy Study Launches; Australia Loosens Psychedelics Access Regulations; VA Launches “New” MDMA Trial
Three Brain Injuries, One Iboga Protocol, and What It Tells Us
The War on Drugs Was Never About Drugs. Psychedelic Healing Must Reckon With That.
A Dispatch from APA’s Annual Meeting: Psychedelics Return at an Awkward Moment for American Psychiatry
Momentum Amidst Tumult: The FDA Reshuffle, Approval Timelines, and the Compass-Usona Race
Braxia Scientific Graduates First Cohort of Medical Professionals from Psilocybin-Assisted Therapy...
U.S. FDA Approves Nova Mentis Orphan Drug Application
Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in...
Cybin Hosting Research and Development Briefing on November 8, 2021
Filament Health Announces FDA Authorization of Clinical Trial with First-Ever Direct...
Field Trip Health Ltd. Schedules Second Fiscal Quarter 2022 Financial Results...
PT269 – Adam Strauss – Comedy, OCD, and The Mushroom Cure
Psychedelic Research Bulletin: October 2021
The Compounds in Psychedelic Cacti
atai Life Sciences Announces Supportive Interim Data from First 8-Patient Cohort...
Load more